Climb Bio, Inc.

NasdaqGM:CLYM Stock Report

Market Cap: US$154.6m

Climb Bio Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:CLYM Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 Jul 24SellUS$988,495Valerie MorissetIndividual129,206US$8.07
18 Jul 24SellUS$289,492Valerie MorissetIndividual41,783US$6.93
16 Jul 24SellUS$356,500Valerie MorissetIndividual50,000US$7.13
15 Jul 24SellUS$650,563Valerie MorissetIndividual92,377US$7.07
11 Jul 24SellUS$736,500Valerie MorissetIndividual105,931US$7.11
05 Jul 24SellUS$87,135Valerie MorissetIndividual12,342US$7.06
03 Jul 24SellUS$286,293Valerie MorissetIndividual42,351US$6.76
27 Jun 24BuyUS$49,952,817RA Capital Management, L.P.Company13,008,546US$3.84

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CLYM?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders545,5230.812%
General Public3,448,4825.13%
Private Companies5,009,4007.45%
Institutions26,801,08839.9%
VC/PE Firms31,419,26746.7%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 143.8%.

Top Shareholders

Top 25 shareholders own 92.07% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
46.7%
RA Capital Management, L.P.
31,419,267US$72.3m0%0.86%
7.45%
Ai Eti Llc
5,009,400US$11.5m0%no data
5.36%
Janus Henderson Group plc
3,606,495US$8.3m10.8%no data
3.88%
Samsara BioCapital LLC
2,609,114US$6.0m-20%0.75%
3.87%
Tavistock Life Sciences
2,603,190US$6.0m0%0.4%
3.23%
Deep Track Capital, LP
2,169,143US$5.0m-44.5%0.15%
2.98%
Intermediate Capital Group plc
2,002,563US$4.6m0%100.0%
2.78%
BlackRock, Inc.
1,867,097US$4.3m389%no data
2.27%
The Vanguard Group, Inc.
1,524,868US$3.5m367%no data
2.23%
Affinity Asset Advisors, LLC
1,500,000US$3.4m-10.2%0.58%
2.17%
LifeArc, Endowment Arm
1,461,538US$3.4m0%no data
1.83%
Ally Bridge Group
1,229,292US$2.8m146%1.11%
1%
T. Rowe Price Group, Inc.
672,566US$1.5m0%no data
0.97%
Geode Capital Management, LLC
651,297US$1.5m280%no data
0.91%
Driehaus Capital Management LLC
612,387US$1.4m-12%0.01%
0.88%
Point72 Asset Management, L.P.
590,946US$1.4m0%no data
0.69%
Pivotal BioVenture Partners LLC
463,654US$1.1m0%0.43%
0.47%
State Street Global Advisors, Inc.
315,036US$724.6k434%no data
0.44%
Northern Trust Global Investments
292,611US$673.0k541%no data
0.41%
Parkman Healthcare Partners LLC
278,775US$641.2k0%0.09%
0.37%
Great Point Partners, LLC
248,168US$570.8k0%0.21%
0.34%
Monashee Investment Management, LLC
230,000US$529.0k0%0.06%
0.27%
Sphera Funds Management Ltd
181,970US$418.5k-15.4%0.07%
0.26%
Adam Rosenberg
178,100US$409.6k0%no data
0.26%
Ikarian Capital, LLC
175,100US$402.7k75.1%0.11%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/07 11:13
End of Day Share Price 2025/01/07 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Climb Bio, Inc. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael DiFioreEvercore ISI
Yatin SunejaGuggenheim Securities, LLC
Marc GoodmanLeerink Partners LLC